REVANCE THERAPEUTICS

Serial Number 90862526
809

Registration Progress

Application Filed
Aug 3, 2021
Under Examination
Feb 15, 2022
Approved for Publication
Dec 21, 2021
Published for Opposition
Dec 21, 2021
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Feb 10, 2026 7 days

Trademark Image

REVANCE THERAPEUTICS

Basic Information

Serial Number
90862526
Filing Date
August 3, 2021
Published for Opposition
December 21, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
809
Status Date
Nov 10, 2025
Application
Pending
Classes
044

Rights Holder

Revance Therapeutics, Inc.

03
Address
207 Mockingbird Lane
Johnson City, TN 37604

Ownership History

Revance Therapeutics, Inc.

Original Applicant
03
Nashville, TN

Revance Therapeutics, Inc.

Owner at Publication
03
Johnson City, TN

Legal Representation

Attorney
Jennifer Waitman

USPTO Deadlines

Next Deadline
7 days remaining
Final Refusal E-Mailed
Due Date
February 10, 2026
Extension Available
Until May 10, 2026

Application History

50 events
Date Code Type Description Documents
Nov 10, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 10, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 10, 2025 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Nov 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 10, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 7, 2025 ALIE A ASSIGNED TO LIE Loading...
Nov 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 30, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 30, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 30, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 30, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 30, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 25, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 25, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 5, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 5, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 5, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 30, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 14, 2025 IUAF S USE AMENDMENT FILED Loading...
Apr 30, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 14, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 13, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 14, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 14, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 14, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 14, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 6, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 4, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 4, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 4, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 21, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 16, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 16, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 16, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 16, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 16, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...

Detailed Classifications

Class 044
Providing medical information regarding pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
First Use Anywhere: Aug 14, 2023
First Use in Commerce: Aug 14, 2023

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"